Mymetics Corp (MYMX):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Mymetics Corp (MYMX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10049
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mymetics Corp (Mymetics) is a biotechnology company that develops next-generation prophylactic vaccines for infectious diseases. The company’s product pipeline includes vaccine candidates that target HIV-1/AIDS, chikungunya, intranasal influenza, malaria, herpes simplex virus (HSV) and respiratory syncytial virus (RSV). Mymetics uses its proprietary technology which deploys virosomes and lipid-based carriers containing viral proteins and natural membrane proteins, in combination with rationally designed antigens or adjuvants to develop vaccines. Its vaccines are designed to induce protection against early transmission and infection. The company has subsidiaries in the Netherlands and Switzerland. It has a research and development facility in Leiden, the Netherlands. Mymetics is headquartered in Epalinges, Switzerland.

Mymetics Corp (MYMX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mymetics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Mymetics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mymetics Corp, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Mymetics Enters into Research Collaboration Agreement with eTheRNA 10
Mymetics and Anergis Enter into Research Partnership 11
Mymetics Enters into Research Agreement with Sanofi 12
Mymetics Enters into Agreement with Texas Biomedical Research Institute 13
Mymetics Enters into Co-Development Agreement with Path Malaria Vaccine Initiative 14
Mymetics Corp – Key Competitors 15
Mymetics Corp – Key Employees 16
Mymetics Corp – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Mymetics Corp, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mymetics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mymetics Corp, Deals By Therapy Area, 2012 to YTD 2018 8
Mymetics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Mymetics Enters into Research Collaboration Agreement with eTheRNA 10
Mymetics and Anergis Enter into Research Partnership 11
Mymetics Enters into Research Agreement with Sanofi 12
Mymetics Enters into Agreement with Texas Biomedical Research Institute 13
Mymetics Enters into Co-Development Agreement with Path Malaria Vaccine Initiative 14
Mymetics Corp, Key Competitors 15
Mymetics Corp, Key Employees 16
Mymetics Corp, Subsidiaries 17

List of Figures
Mymetics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Mymetics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Mymetics Corp (MYMX):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • British American Tobacco Bangladesh:企業の戦略・SWOT・財務情報
    British American Tobacco Bangladesh - Strategy, SWOT and Corporate Finance Report Summary British American Tobacco Bangladesh - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Advantage Oil & Gas Ltd (AAV):石油・ガス:M&Aディール及び事業提携情報
    Summary Advantage Oil & Gas Ltd (Advantage Oil & Gas) is an upstream company. It is involved in exploitation, acquisition, development, and production of crude oil, natural gas and natural gas liquids in Alberta. The company’s exploitation and development program is focused on Glacier assets and the …
  • Volkswind GmbH-エネルギー分野:企業M&A・提携分析
    Summary Volkswind GmbH (Volkswind), a subsidiary of Axpo Holding AG, is an independent renewable power producer. It undertakes the planning, development, construction and operations of wind power plants. Volkswind builds wind farms with wind turbines from various suppliers including Seimens, Enercon …
  • A-Sonic Aerospace Limited:企業の戦略・SWOT・財務分析
    A-Sonic Aerospace Limited - Strategy, SWOT and Corporate Finance Report Summary A-Sonic Aerospace Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Domino’S Pizza Group Plc
    Domino'S Pizza Group Plc - Strategy, SWOT and Corporate Finance Report Summary Domino'S Pizza Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Bush Industries Inc:企業の戦略・SWOT・財務情報
    Bush Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Bush Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Hoteli Maestral d.d.:企業の戦略・SWOT・財務情報
    Hoteli Maestral d.d. - Strategy, SWOT and Corporate Finance Report Summary Hoteli Maestral d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • MIS Implants Technologies Ltd-医療機器分野:企業M&A・提携分析
    Summary MIS Implants Technologies Ltd (MIS) is a medical device company that offers advanced products and solutions for dental implantology treatment. The company offers dental implants, tools and kits, superstructures, and solutions for oral restoration and health, among others. Its implants compri …
  • PT Kimia Farma (Persero) Tbk (KAEF):製薬・医療:M&Aディール及び事業提携情報
    Summary PT Kimia Farma (Persero) Tbk (Kimia Farma) manufactures, commercializes and distributes pharmaceutical products. The company provides ethical (prescription), generic and other products. It offers products in various categories including alimentary system, allergy and immune system, system an …
  • Mecklenburg Electric Cooperative:発電所・企業SWOT分析
    Mecklenburg Electric Cooperative - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • Westinghouse Electric Co LLC:企業の戦略的SWOT分析
    Westinghouse Electric Co LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Savara Inc (SVRA):企業の財務・戦略的SWOT分析
    Savara Inc (SVRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Nexstim Plc (NXTMH):医療機器:M&Aディール及び事業提携情報
    Summary Nexstim Plc (Nexstim) focuses on navigated, non-invasive brain stimulation therapy and diagnosis based on E-field navigated neuro stimulation technology (eTMS). Its NBS system applies the technology for pre-surgical mapping of the motor and speech cortices. It is also used for research, ther …
  • ProPhotonix Limited (STKR):企業の財務・戦略的SWOT分析
    ProPhotonix Limited (STKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Biosense Webster Inc:企業の製品パイプライン分析
    Summary Biosense Webster Inc (Biosense Webster), a subsidiary of Johnson & Johnson, is a medical device company that designs, manufactures and markets cardiac arrhythmias products. The company’s products include ablation catheters, diagnostic catheters and access, ultrasound catheters and 3D cardiac …
  • Victory Resources Corporation:企業の戦略・SWOT・財務情報
    Victory Resources Corporation - Strategy, SWOT and Corporate Finance Report Summary Victory Resources Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Moog Inc (MOG.A):企業の財務・戦略的SWOT分析
    Moog Inc (MOG.A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Unilever Pakistan Limited:企業の戦略・SWOT・財務分析
    Unilever Pakistan Limited - Strategy, SWOT and Corporate Finance Report Summary Unilever Pakistan Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Veritas (India) Ltd:企業の戦略・SWOT・財務分析
    Veritas (India) Ltd - Strategy, SWOT and Corporate Finance Report Summary Veritas (India) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Bosch Rexroth AG:企業の戦略的SWOT分析
    Bosch Rexroth AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆